Up to 20,000 people have died needlessly early after being denied cancer drugs on the NHS, it was revealed yesterday.
The rationing body NICE has failed to keep a promise to make more life-extending drugs available.
Treatments used widely in the U.S. and Europe have been rejected on grounds of cost-effectiveness, yet patients and their loved ones have seen the NHS waste astronomical sums.
Last week it emerged that £21billion – a fifth of the entire annual budget – was spent on failed schemes to tackle inequality.
Full story: NICE rejects cancer drugs that could have extended patients’ lives | Mail Online